Samira Mohammad Mirzapour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Samira Mohammad Mirzapour has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Motahare Sharifyrad
Pharmaceutical Nanotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran
2 shared publications - Adileh Shirmohammadi
Dental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication - Asieh Mozaffari
Department of Periodontics, Faculty of Dentistry, Qazvin University of Medical Sciences, Qazvin, Iran
1 shared publication - Atabak Kashefimehr
Department of Periodontics, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication - Elnaz Ziaei-Rad
Department of Periodontics, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication - Fatemeh Aghaziarati
Department of Periodontics, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication
Latest Publications
- Open Access
- 22 December 2025
- Published by Maad Rayan Publishing Company in Journal of Advanced Periodontology & Implant Dentistry
- Vol. 18 (2) , 103-113
Development and evaluation of a PLGA/TiO 2 nanocomposite for periodontal applications: Synthesis, characterization, and cytocompatibility with human gingival fibroblasts—An in vitro study
Background. Titanium dioxide (TiO2) nanoparticles exhibit promising antibacterial and structural properties but raise concerns of cytotoxicity in oral soft tissues. Incorporating TiO2 into biocompatible polymers such as poly(lactic-co-glycolic acid) (PLGA) may reduce these adverse effects and improve clinical applicability in periodontal therapy. Methods. TiO2 nanoparticles were synthesized via a modified sol–gel method and incorporated into PLGA matrices with and without polyvinylpyrrolidone (PVP) as a stabilizer. The formulations were characterized using Fourier-transform infrared (FTIR) spectroscopy, field emission scanning electron microscopy (FESEM), thermogravimetric analysis (TGA), dynamic light scattering (DLS), and x-ray diffraction (XRD). Cytocompatibility was evaluated using the MTT assay on HGF cells across concentrations of 1–100 μg/mL after 24 and 48 h. Results. TiO2 nanoparticles alone induced significant, dose- and time-dependent cytotoxicity, reducing cell viability to ~45% at 100 μg/mL after 48 h (P90% cell viability at all tested concentrations. The PLGA/TiO2 nanocomposite showed markedly reduced cytotoxicity, maintaining>80% viability even at 100 μg/mL. Incorporation of PVP improved nanoparticle dispersion, as confirmed by FESEM and DLS, and enhanced the thermal stability of the composite. Conclusion. Encapsulation of TiO2 within a PLGA matrix significantly mitigated cytotoxicity while preserving structural stability, with PVP further improving homogeneity and heat resistance. These findings highlight the potential of PLGA/TiO2 nanocomposites as safe and effective candidates for periodontal wound dressings, implant coatings, or regenerative scaffolds.
- 22 December 2025
- Published by Maad Rayan Publishing Company in Journal of Advanced Periodontology & Implant Dentistry
- Vol. 18 (2) , 103-113
Open AccessDevelopment and evaluation of a PLGA/TiO 2 nanocomposite for periodontal applications: Synthesis, characterization, and cytocompatibility with human gingival fibroblasts—An in vitro study
Background. Titanium dioxide (TiO2) nanoparticles exhibit promising antibacterial and structural properties but raise concerns of cytotoxicity in oral soft tissues. Incorporating TiO2 into biocompatible polymers such as poly(lactic-co-glycolic acid) (PLGA) may reduce these adverse effects and improve clinical applicability in periodontal therapy. Methods. TiO2 nanoparticles were synthesized via a modified sol–gel method and incorporated into PLGA matrices with and without polyvinylpyrrolidone (PVP) as a stabilizer. The formulations were characterized using Fourier-transform infrared (FTIR) spectroscopy, field emission scanning electron microscopy (FESEM), thermogravimetric analysis (TGA), dynamic light scattering (DLS), and x-ray diffraction (XRD). Cytocompatibility was evaluated using the MTT assay on HGF cells across concentrations of 1–100 μg/mL after 24 and 48 h. Results. TiO2 nanoparticles alone induced significant, dose- and time-dependent cytotoxicity, reducing cell viability to ~45% at 100 μg/mL after 48 h (P90% cell viability at all tested concentrations. The PLGA/TiO2 nanocomposite showed markedly reduced cytotoxicity, maintaining>80% viability even at 100 μg/mL. Incorporation of PVP improved nanoparticle dispersion, as confirmed by FESEM and DLS, and enhanced the thermal stability of the composite. Conclusion. Encapsulation of TiO2 within a PLGA matrix significantly mitigated cytotoxicity while preserving structural stability, with PVP further improving homogeneity and heat resistance. These findings highlight the potential of PLGA/TiO2 nanocomposites as safe and effective candidates for periodontal wound dressings, implant coatings, or regenerative scaffolds.
- Open Access
- 2 December 2025
- Published by Maad Rayan Publishing Company in Journal of Advanced Periodontology & Implant Dentistry
- Vol. 18 (1) , 32-40
Effect of autogenous tooth vs. autogenous bone grafts on periodontal phenotype around immediate implants: A randomized clinical trial
Background. Immediate implant placement can result in a horizontal defect between the implant and alveolar bone, potentially affecting osseointegration and esthetic outcomes. Grafting this space supports bone regeneration. This study compared the effectiveness of autogenous tooth-derived and autogenous bone grafts for horizontal gap augmentation in the maxillary anterior region. Methods. This parallel-arm randomized, single-masked clinical trial enrolled patients attending the Tabriz University of Medical Sciences School of Dentistry, who were candidates for immediate implant placement in the maxillary anterior region. After implant placement, the control sites (n=11) received autogenous bone grafts. In contrast, the intervention sites (n=11) received autogenous dentin grafts to fill the horizontal gap between the implant and the buccal wall (jumping gap). A connective tissue graft was subsequently placed in both groups to enhance buccal soft tissue. Buccal bone thickness (measured 2 mm and 5 mm below the marginal crest) and soft tissue thickness were measured at two points at the time of surgery and again six months postoperatively. Data were analyzed using paired t-tests to assess changes within each group and independent t-tests to compare differences between the two groups. Results. Both groups showed significant increases in buccal bone and soft tissue thickness compared with baseline. At 2 mm below the marginal crest, buccal bone thickness did not differ significantly between the two groups (P=0.401). At 5 mm below the marginal crest, the autogenous bone graft group showed significantly greater bone thickness (2.15±0.21 mm) than the dentin graft group (1.50±0.53 mm, P=0.001). There was no significant difference in buccal soft tissue thickness changes between the bone graft (1.15±0.18 mm) and dentin graft (1.1±0.17 mm) groups. Conclusion. Both autogenous dentin and bone grafts effectively enhanced buccal bone and soft tissue thickness around immediate implants. Autogenous bone grafts produced significantly greater increases in buccal bone at 5 mm below the marginal crest. Trial Registration. Iranian Registry of Clinical Trials (IRCT), IRCT20110726007128N11, Trial ID 86072.
- 2 December 2025
- Published by Maad Rayan Publishing Company in Journal of Advanced Periodontology & Implant Dentistry
- Vol. 18 (1) , 32-40
Open AccessEffect of autogenous tooth vs. autogenous bone grafts on periodontal phenotype around immediate implants: A randomized clinical trial
Background. Immediate implant placement can result in a horizontal defect between the implant and alveolar bone, potentially affecting osseointegration and esthetic outcomes. Grafting this space supports bone regeneration. This study compared the effectiveness of autogenous tooth-derived and autogenous bone grafts for horizontal gap augmentation in the maxillary anterior region. Methods. This parallel-arm randomized, single-masked clinical trial enrolled patients attending the Tabriz University of Medical Sciences School of Dentistry, who were candidates for immediate implant placement in the maxillary anterior region. After implant placement, the control sites (n=11) received autogenous bone grafts. In contrast, the intervention sites (n=11) received autogenous dentin grafts to fill the horizontal gap between the implant and the buccal wall (jumping gap). A connective tissue graft was subsequently placed in both groups to enhance buccal soft tissue. Buccal bone thickness (measured 2 mm and 5 mm below the marginal crest) and soft tissue thickness were measured at two points at the time of surgery and again six months postoperatively. Data were analyzed using paired t-tests to assess changes within each group and independent t-tests to compare differences between the two groups. Results. Both groups showed significant increases in buccal bone and soft tissue thickness compared with baseline. At 2 mm below the marginal crest, buccal bone thickness did not differ significantly between the two groups (P=0.401). At 5 mm below the marginal crest, the autogenous bone graft group showed significantly greater bone thickness (2.15±0.21 mm) than the dentin graft group (1.50±0.53 mm, P=0.001). There was no significant difference in buccal soft tissue thickness changes between the bone graft (1.15±0.18 mm) and dentin graft (1.1±0.17 mm) groups. Conclusion. Both autogenous dentin and bone grafts effectively enhanced buccal bone and soft tissue thickness around immediate implants. Autogenous bone grafts produced significantly greater increases in buccal bone at 5 mm below the marginal crest. Trial Registration. Iranian Registry of Clinical Trials (IRCT), IRCT20110726007128N11, Trial ID 86072.
- Open Access
- 3 March 2025
- Published by Maad Rayan Publishing Company in Journal of Advanced Periodontology & Implant Dentistry
- Vol. 17 (1) , 1-14
Stem cell therapy for regenerating periodontal bony defects: A narrative review
Periodontal bony defects pose a significant challenge in periodontology, necessitating advanced regenerative approaches to restore the lost structures. Stem cell-based therapies have emerged as a promising solution due to their ability to differentiate into various cells, modulating the regenerative microenvironment. This narrative review explores the potential of stem cells derived from multiple sources in treating periodontal bony defects. Additionally, we examine evidence from both animal and human studies, highlighting advancements, clinical outcomes, and limitations. By investigating these findings, this article provides a comprehensive overview of the advantages of stem cell-based therapies compared to other regenerative techniques in addressing periodontal bony defects and discusses the limitations of their translation into routine clinical practice.
- 3 March 2025
- Published by Maad Rayan Publishing Company in Journal of Advanced Periodontology & Implant Dentistry
- Vol. 17 (1) , 1-14
Open AccessStem cell therapy for regenerating periodontal bony defects: A narrative review
Periodontal bony defects pose a significant challenge in periodontology, necessitating advanced regenerative approaches to restore the lost structures. Stem cell-based therapies have emerged as a promising solution due to their ability to differentiate into various cells, modulating the regenerative microenvironment. This narrative review explores the potential of stem cells derived from multiple sources in treating periodontal bony defects. Additionally, we examine evidence from both animal and human studies, highlighting advancements, clinical outcomes, and limitations. By investigating these findings, this article provides a comprehensive overview of the advantages of stem cell-based therapies compared to other regenerative techniques in addressing periodontal bony defects and discusses the limitations of their translation into routine clinical practice.
- Open Access
- 3 June 2023
- Published by Maad Rayan Publishing Company in Journal of Advanced Periodontology & Implant Dentistry
- Vol. 15 (1) , 27-33
Cytotoxicity of PLGA-zinc oxide nanocomposite on human gingival fibroblasts
Background. Polylactic-co-glycolic acid and zinc oxide (PLGA-ZnO) nanocomposite has been investigated for its antibacterial properties, which could be beneficial for adding to wound dressings after periodontal surgery. However, its cytotoxicity against human gingival fibroblasts (HGFs) remains unclear and should be evaluated. Methods. ZnO nanoparticles were synthesized using the hydrothermal method. These metallic nanoparticles were incorporated into the PLGA matrix by the solvent/non-solvent process. The nanomaterial was evaluated by field emission scanning electron microscopy (FESEM), Fourier transform infrared (FTIR), thermogravimetric analysis (TGA), and x-ray diffraction (XRD) analyses. HGF cells were acquired from the National Cell Bank and categorized into four groups: ZnO, PLGA, ZnO-PLGA, and control. The cells were exposed to different ZnO (1, 20, 40, 60, 80, and 100 µg/mL) and PLGA (0.2, 4, 8, 12, 16, and 20 µg/mL) concentrations for 24 and 48 hours. The cytotoxicity was tested using the MTT assay. The data were analyzed using SPSS 25, and P<0.05 was considered statistically significant. Results. ZnO nanoparticles exhibited significant toxicity at≥40 µg/mL concentrations after 24 hours. Cell viability decreased significantly at all the tested concentrations after 48 hours of exposure. PLGA-ZnO cell viability in 24 hours was similar to the control group for all the concentrations up to 80 µg/mL. Conclusion. ZnO nanoparticles could be toxic against HGF in high concentrations and with prolonged exposure. Therefore, incorporating ZnO nanoparticles into a biocompatible polymer such as PLGA could be a beneficial strategy for reducing their toxicity.
- 3 June 2023
- Published by Maad Rayan Publishing Company in Journal of Advanced Periodontology & Implant Dentistry
- Vol. 15 (1) , 27-33
Open AccessCytotoxicity of PLGA-zinc oxide nanocomposite on human gingival fibroblasts
Background. Polylactic-co-glycolic acid and zinc oxide (PLGA-ZnO) nanocomposite has been investigated for its antibacterial properties, which could be beneficial for adding to wound dressings after periodontal surgery. However, its cytotoxicity against human gingival fibroblasts (HGFs) remains unclear and should be evaluated. Methods. ZnO nanoparticles were synthesized using the hydrothermal method. These metallic nanoparticles were incorporated into the PLGA matrix by the solvent/non-solvent process. The nanomaterial was evaluated by field emission scanning electron microscopy (FESEM), Fourier transform infrared (FTIR), thermogravimetric analysis (TGA), and x-ray diffraction (XRD) analyses. HGF cells were acquired from the National Cell Bank and categorized into four groups: ZnO, PLGA, ZnO-PLGA, and control. The cells were exposed to different ZnO (1, 20, 40, 60, 80, and 100 µg/mL) and PLGA (0.2, 4, 8, 12, 16, and 20 µg/mL) concentrations for 24 and 48 hours. The cytotoxicity was tested using the MTT assay. The data were analyzed using SPSS 25, and P<0.05 was considered statistically significant. Results. ZnO nanoparticles exhibited significant toxicity at≥40 µg/mL concentrations after 24 hours. Cell viability decreased significantly at all the tested concentrations after 48 hours of exposure. PLGA-ZnO cell viability in 24 hours was similar to the control group for all the concentrations up to 80 µg/mL. Conclusion. ZnO nanoparticles could be toxic against HGF in high concentrations and with prolonged exposure. Therefore, incorporating ZnO nanoparticles into a biocompatible polymer such as PLGA could be a beneficial strategy for reducing their toxicity.